Historical record - last NADAC effective date: 6/21/2023
Product Information
QC IBUPROFEN 200 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0350 per EA under NDC 63868077305. Its NADAC has been published 228 times since Feb 20, 2019.
FDA first approved this application on Mar 1, 1999.
Strength
200 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868077305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA075010FDA Approved
3/1/1999
On Market Since
5/24/1988
Pharmacological Classes
Price Statistics
The NADAC for QC IBUPROFEN 200 MG TABLET has been published 228 times since Feb 20, 2019, and over the history we have for it it has risen 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0350 per EA |
|---|---|
| All-time high | $0.0359 (Mar 11, 2020) |
| All-time low | $0.0284 (Feb 20, 2019) |
| Median price | $0.0334 |
| Average price | $0.0332 |
| Largest weekly change | +9.2% (Jul 20, 2022) |
| Weeks tracked | 228 |
| Tracking since | Feb 20, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+4.5%
All
+23.2%
Last surveyed Jun 28, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC IBUPROFEN 200 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0350 per EA (NDC 63868077305), effective Jun 28, 2023.
How has the price of QC IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC IBUPROFEN 200 MG TABLET has risen 23.2%. It has been tracked across 228 weekly CMS publications since Feb 20, 2019.
What are the highest and lowest recorded NADAC prices for QC IBUPROFEN 200 MG TABLET?
Since Feb 20, 2019, the NADAC for QC IBUPROFEN 200 MG TABLET has ranged from a low of $0.0284 (Feb 20, 2019) to a high of $0.0359 (Mar 11, 2020), with a median of $0.0334 per EA.
Are there cheaper alternatives to QC IBUPROFEN 200 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 23% below QC IBUPROFEN 200 MG TABLET.
Who manufactures QC IBUPROFEN 200 MG TABLET?
QC IBUPROFEN 200 MG TABLET (NDC 63868077305) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.